Source: Revive Therapeutics Ltd.
  • Revive Therapeutics (RVV) has closed a private placement for gross proceeds of $4.3 million
  • The company issued 28,676,064 units priced at C$0.15 per unit
  • The company paid finders fees totalling $304,112.75 in cash and 2,294,085 finder warrants
  • Revive is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders
  • Revive Therapeutics Ltd. (RVV) opened trading at C$0.13

Revive Therapeutics (RVV) has closed its previously-announced private placement for gross proceeds of$4,301,409.

The company issued a total of 28,676,064 units for $0.15 per unit. Each unit consists of one common share and one common share purchase warrant.  Each warrant entitles the holder to acquire one additional common share for a period of three years from the closing date of the offering.

The company paid $304,112.75 in cash and 2,294,085 finder warrants to EMD Financial Inc. and other registrants.

The offering is subject to the receipt of all necessary regulatory approvals.

Revive is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders.

Revive Therapeutics Ltd. (RVV) opened trading at C$0.13.


More From The Market Online

Bitfarms upgrades mining fleet before Bitcoin halving

Global Bitcoin miner Bitfarms (TSX:BITF) is continuing to post strong production results as the Bitcoin halving grows near.
markets

@ the Bell: Major markets surge into March

The TSX began March by rallying for a second consecutive day as it joined other major global stock markets to finish the week strong.
Complexity Gaming

GameSquare sells Complexity Gaming for US$10.36 million

GameSquare Holdings, Inc. (TSX.V:GAME; NASDAQ:GAME) has announced it sold its Complexity Gaming e-sports team for US$10.36 million.